Halozyme Therapeutics, Inc. vs. Krystal Biotech, Inc. Common Stock
HALO
Halozyme Therapeutics, Inc.
$91.35 -1.82%
VS KRYSKrystal Biotech, Inc. Common Stock
$308.89 -2.19%
Halozyme Therapeutics, Inc. and Krystal Biotech, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | KRYS | |
|---|---|---|
| Market Cap | $10.41 billion | $9.15 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| HALO | KRYS | |
|---|---|---|
| Short Interest | 9.75% | 0.11% |
KRYS leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, KRYS overview, KRYS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
